Market Size of Asia-Pacific Contraceptive Drugs and Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.39 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
APAC Contraceptives Market Analysis
The Asia-Pacific contraceptive drugs and devices market is anticipated to record a CAGR of 6.39%, during the forecast period. The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.
APAC Contraceptives Industry Segmentation
In basic terms, contraceptives refer to a set of devices, methods, medications, and techniques that are used to control births. The use of contraceptive pills, hormonal IUD, copper IUD, condoms, diaphragm, injections, and cervical cap are some commonly used contraceptive methods.
| By Product | |||||||||
| |||||||||
|
| By Gender | |
| Male | |
| Female |
| Geography | ||||||||
|
Asia-Pacific Contraceptive Drugs and Devices Market Size Summary
The Asia-Pacific contraceptive drugs and devices market is experiencing significant growth, driven by the increasing need to prevent unwanted pregnancies and manage related health complications. This demand is particularly pronounced among teenage women, highlighting the importance of contraceptive solutions in this demographic. Additionally, many women are turning to contraceptives for non-contraceptive health benefits, such as alleviating menstrual pain and treating acne, further propelling market expansion. The rising incidence of sexually transmitted diseases and the rapid population growth in the region are also contributing factors to the market's upward trajectory. Oral contraceptive pills, known for their ease of use and effectiveness, are particularly popular, making them a key product in the market.
The competitive landscape of the Asia-Pacific contraceptive market is characterized by the presence of several major players who hold significant market shares. Companies such as Bayer AG, Pfizer Inc., Merck & Co. Inc., CooperSurgical Inc., and Allergan PLC are leading the market, with some engaging in strategic acquisitions and joint ventures to strengthen their positions. These activities are aimed at consolidating their influence across the region, ensuring they remain at the forefront of the market's growth during the forecast period. The combination of strategic business maneuvers and the increasing demand for contraceptive solutions underscores the dynamic nature of the market.
Asia-Pacific Contraceptive Drugs and Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidence of the STDs
-
1.2.2 Increasing Rate of Unintended Pregnancies
-
1.2.3 Rise in Government Initiatives
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Devices and Treatment
-
1.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 By Drugs
-
2.1.1.1 Oral Contraceptives
-
2.1.1.2 Topical Contraceptives
-
2.1.1.3 Contraceptive Injectable
-
-
2.1.2 By Device
-
2.1.2.1 Condoms
-
2.1.2.2 Diaphragms
-
2.1.2.3 Cervical Caps
-
2.1.2.4 Sponges
-
2.1.2.5 Vaginal Rings
-
2.1.2.6 IUD
-
2.1.2.7 Other Devices
-
-
-
2.2 By Gender
-
2.2.1 Male
-
2.2.2 Female
-
-
2.3 Geography
-
2.3.1 Asia-Pacific
-
2.3.1.1 China
-
2.3.1.2 Japan
-
2.3.1.3 India
-
2.3.1.4 Australia
-
2.3.1.5 South korea
-
2.3.1.6 Rest of Asia-Pacific
-
-
-
Asia-Pacific Contraceptive Drugs and Devices Market Size FAQs
What is the current Asia-Pacific Contraceptive Drugs and Devices Market size?
The Asia-Pacific Contraceptive Drugs and Devices Market is projected to register a CAGR of 6.39% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Contraceptive Drugs and Devices Market?
Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc. and Allergan PLC are the major companies operating in the Asia-Pacific Contraceptive Drugs and Devices Market.
